Researchers at the Indian Institute of Technology (IIT) Bombay have developed a simpler and more efficient method to recover ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...

Researchers at IIT Bombay have developed a simpler and more efficient method to recover immune cells grown in the lab for T-cell–based cancer therapies ...

UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors ...

The potential of microrobots is enormous. These miniature objects can be designed to carry out actions within the body, such ...

A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed tumor growth or activate immune cells against the cancer​, according to ...

Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...

Over the past two decades, researchers have learned that DNA inside the cell nucleus naturally folds into a network of ...

A novel gel might help combat resistant bacteria in wounds and around implant sites while also promoting recovery. The ...

Committee for Medicinal Products for Human Use (CHMP) issues a positive opinion following re-examination, which will be ...